Yangling Keyspharma Co.Limited, established in 2011, has expanded a compositive entity from initially only as a small laboratory. The company dedicated to the development, production and marketing of chemicals. Main products Roflumilast (CAS?162401-32-3);Roflumilast InterMediate (CAS:162401-62-9);Hydroxytyrosol (CAS:10597-60-1);Sclareolide(CAS:564-20-5);(?)-Ambroxide(CAS:6790-58-5). Keyspharma focus on: -Organic compounds -Active Pharmaceutical Ingredient(s) -Nutritional products -Custom synthesis -Contract Manufacturing